Where is Freenome headquartered?

Freenome is located in South San Francisco, CA.

Who invested in Freenome?

Freenome has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Freenome?

Freenome closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

freenome.com

Freenome

Freenome is a California-based biotechnology company that develops a multiomics platform for early detection of cancer.

Business Model:

Revenue: $22M

Employees: 201-500

Geographic Data

Address: 279 East Grand Avenue

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

corporate round

Raised Last:

$290M

Raised Total:

$1B

Social

Facebook

Twitter

Crunchbase

Metrics

1,527,279Website Global Rank

14,223Website Monthly Traffic

Twitter Followers

Description

Freenome is a California-based biotechnology company that develops a multiomics platform for early detection of cancer.

Contact Phone:
+18317046883

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2017	Series A	12	$65M	Andreessen Horowitz Charles River Associates S28 Capital Polaris Partners Innovation Endeavors GV Founders Fund DCVC Asset Management Ventures (AMV) AME Cloud Ventures Andreessen Horowitz
12/2014	Seed Round	1	-	Loxbridge Research Loxbridge Research
8/2020	Series C		$270M	Bain Capital Life Sciences Perceptive Advisors, LLC Fidelity Management & Research Company Janus Henderson Investors Farallon Capital Management Rock Springs Capital EcoR1 Capital, LLC, Catalio Capital Management Colorectal Cancer Alliance RA Capital Management T. Rowe Price BrightEdge Ventures Sands Capital Andreesen Horowitz Data Collective GV Kaiser Permanente Ventures, novartis Polaris Partners Soleus Capital Section 32
6/2019	Series B		$160M	RA Capital Management Polaris Partners Perceptive Advisors T. Rowe Price Associates, Inc., Kaiser Permanente Ventures BrightEdge Ventures Andreessen Horowitz GV Data Collective Section 32 Verily Life Sciences
8/2020	Series C	22	$270M	Bain Capital Life Sciences Perceptive Advisors Andreessen Horowitz BrightEdge Fund Catalio Capital Management Cormorant Asset Management DCVC EcoR1 Capital Farallon Capital Management Fidelity Management and Research Company GV Janus Henderson Investors Kaiser Permanente Ventures Novartis Polaris Partners RA Capital Management Roche Venture Fund Rock Springs Capital Sands Capital Ventures Section 32 Soleus Capital T. Rowe Price Bain Capital Life Sciences Perceptive Advisors
12/2021	Series D	31	$300M	Novartis Kaiser Permanente Polaris Partners Pura Vida Investments Andreessen Horowitz RA Capital Management Artis Ventures (AV) Eventide Bain Capital Life Sciences Logos Capital Perceptive Advisors RA Capital Management ArrowMark Partners BrightEdge Fund Byers Capital Catalio Capital Management Cormorant Capital DCVC Farallon Capital Management Fidelity Management and Research Company GV HBM Healthcare Investments AG Intermountain Ventures Janus Henderson Investors Ridgeback Capital Roche Venture Fund Rock Springs Capital Sands Capital Ventures Section 32 Soleus Capital Suvretta Capital Management T. Rowe Price Polaris Partners Pura Vida Investments Kaiser Permanente Andreessen Horowitz RA Capital Management Artis Ventures (AV) Eventide Bain Capital Life Sciences Logos Capital Perceptive Advisors RA Capital Management
2/2017	Series A		$72M	Andreessen Horowitz GV Polaris Partners Innovation Endeavors Spectrum 28 Asset Management Ventures Charles River Ventures AME Cloud Ventures Allen and Company Section 32
1/2022	Corporate Round	1	$290M	Roche Roche Roche
6/2016	Seed Round	4	$5.5M	Andreessen Horowitz Third Kind Venture Capital Founders Fund DCVC Andreessen Horowitz
7/2019	Series B	16	$160M	Polaris Partners RA Capital Management Verily T. Rowe Price Soleus Capital Section 32 Roche Venture Fund Perceptive Advisors Longevity Vision Fund Kaiser Permanente Ventures Polaris Partners RA Capital Management
8/2017	Series A	12	$7M	Section 32 Verily S28 Capital Polaris Partners Innovation Endeavors GV Founders Fund DCVC CRV Asset Management Ventures (AMV) Section 32
12/2014	Seed Round	1	-	Loxbridge Research Loxbridge Research

Acquisitions

Announced Date	Name	Price
5/2023	Oncimmune

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details